Birmingham Vivo Bioscience announced entering an R&D collaboration for development of cell-based assays for the xCELLigence System, co-developed by Roche-ACEA and marketed by Roche Applied Science. Details here. The B'ham BJ says the deal is worth about $2MM now for Vivo.
Showing posts with label Vivo Bioscience. Show all posts
Showing posts with label Vivo Bioscience. Show all posts
Friday, October 29, 2010
B'ham Vivo BioScience in Roche-ACEA pact
Birmingham Vivo Bioscience announced entering an R&D collaboration for development of cell-based assays for the xCELLigence System, co-developed by Roche-ACEA and marketed by Roche Applied Science. Details here. The B'ham BJ says the deal is worth about $2MM now for Vivo.
Labels:
biotechnology,
cancer,
Vivo Bioscience
Subscribe to:
Posts (Atom)